0001887377-22-000001.txt : 20220309 0001887377-22-000001.hdr.sgml : 20220309 20220309133751 ACCESSION NUMBER: 0001887377-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220309 DATE AS OF CHANGE: 20220309 EFFECTIVENESS DATE: 20220309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aquyre Biosciences Inc CENTRAL INDEX KEY: 0001887377 IRS NUMBER: 272412843 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-436532 FILM NUMBER: 22724843 BUSINESS ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 33 1 82 72 61 25 MAIL ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 D 1 primary_doc.xml X0708 D LIVE 0001887377 Aquyre Biosciences Inc 50 MILK STREET 16TH FLOOR BOSTON MA MASSACHUSETTS 02109 33 1 82 72 61 25 DELAWARE LLTech, Inc. None Corporation true Bertrand Le Conte Chrestien de Poly 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director Aurelio Fernandez 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Ari Azhir 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Thierry Thaure 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director Aldo Maccari 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Other Decline to Disclose 06b false 2022-02-25 false true false 0 Aegis Special Situations QP Fund LLC ? Series Medtech IV 15007 Ceros Financial Services, Inc. 37869 1445 Research Boulevard Rockville MD MARYLAND 20850 NY NEW YORK false 2000000 2000000 0 false 1 224640 0 Ceros Financial Services, Inc. received $224,640 and 15,360 shares of Series A-2 Preferred Stock at $11.70 price per share. 0 false Aquyre Biosciences Inc /s/Bertrand Le Conte Chrestien Bertrand Le Conte Chrestien de Poly President & CEO 2022-03-09